How Much Does Losartan Cost in California in 2026?

California Cash Prices for Losartan in 2026

The average cash price for a 30-day supply of generic losartan 50 mg across California retail pharmacies in 2026 sits near $10 per month. That figure comes from aggregated pharmacy pricing data statewide, but actual out-of-pocket cost varies by pharmacy, dosage, and whether you use a discount card.

At chains like Costco, Walmart, and select Kroger-affiliated pharmacies (including Ralphs, which operates throughout California), losartan appears on $4-per-month generic drug lists. These programs do not require insurance. You present a prescription, pay $4, and leave. CVS and Walgreens typically charge $9 to $15 for the same supply without a discount card, and $5 to $8 with one.

The brand-name version, Cozaar (manufactured by Merck), carries a list price around $80 per month. Almost no pharmacy in California dispenses it unless a prescriber writes "dispense as written" on the prescription. Generic losartan potassium tablets are therapeutically equivalent (FDA "AB" rated), and every major insurer and pharmacy benefit manager substitutes automatically. Losartan first lost patent exclusivity in April 2010, and over a dozen generic manufacturers now compete in the U.S. market, which is the primary reason the price has fallen so sharply over the past 16 years.

For patients taking the 100 mg dose, expect roughly 10 to 20% higher prices at cash-pay rates compared to the 50 mg strength. The 25 mg tablet, often used as a starting dose in older adults or those with hepatic impairment per the FDA-approved labeling, tends to cost the same as the 50 mg tablet at most pharmacies.

Medi-Cal Coverage for Losartan

Medi-Cal, California's Medicaid program, covers losartan. The drug requires prior authorization (PA), a step that adds a small administrative hurdle but does not typically result in denial for standard hypertension indications.

Prior authorization for losartan under Medi-Cal usually involves the prescribing clinician confirming that the patient has a qualifying diagnosis (hypertension, diabetic nephropathy, or stroke risk reduction in patients with left ventricular hypertrophy) and that the prescribed dose aligns with clinical guidelines. The 2017 ACC/AHA Hypertension Guideline lists angiotensin II receptor blockers (ARBs) like losartan as first-line agents for most adults with stage 1 or stage 2 hypertension, which makes PA approval routine in practice.

For Medi-Cal managed care enrollees (the majority of the program's roughly 15 million beneficiaries), the specific managed care plan may have its own formulary preferences. Some plans prefer losartan; others prefer valsartan or irbesartan. If your plan denies losartan and approves a different ARB, switching is medically reasonable because the ARB class shares a common mechanism of action: selective blockade of the angiotensin II type 1 (AT1) receptor [1]. If a clinician documents a specific reason for losartan (for example, prior tolerability or a diabetic nephropathy indication based on the RENAAL trial data), the PA is usually granted.

Medi-Cal copays are either $0 or $1 for generic drugs, depending on the enrollee category. That makes the effective cost of losartan through Medi-Cal far below even the cheapest cash-pay options.

Insurance Coverage Beyond Medi-Cal

Every major commercial health insurer operating in California places generic losartan on its lowest formulary tier. This applies to plans sold through Covered California (the state's ACA marketplace), employer-sponsored plans, and Medicare Part D.

Tier 1 generic copays in California typically range from $0 to $15, depending on the plan. For most enrollees, the insurance copay and the cash price are similar enough that using a discount card instead of insurance can sometimes be cheaper. This is legal. California pharmacies are permitted to process a transaction through a discount program rather than a patient's insurance if the patient requests it, and doing so does not affect the patient's coverage for other medications.

Medicare Part D covers losartan as well. Under the Inflation Reduction Act provisions that took effect in 2025, Part D out-of-pocket costs are capped at $2,000 per year, but losartan is unlikely to push anyone near that threshold. Most Part D plans charge $0 to $10 per month for generic ARBs. The CMS Medicare Plan Finder allows beneficiaries to check their specific plan's losartan cost by entering their ZIP code.

Kaiser Permanente, which covers more than 8 million Californians, includes losartan on its standard formulary. Blue Shield of California, Anthem Blue Cross, Health Net, and Molina similarly list generic losartan at their lowest cost-sharing tier. No major California insurer currently requires step therapy or PA for generic losartan on commercial plans. That PA requirement is specific to Medi-Cal and certain Medi-Cal managed care contracts.

Discount Programs and Savings Cards

Several pathways can reduce losartan costs even further for uninsured or underinsured Californians.

$4 generic lists. Walmart, Costco, and Ralphs (Kroger) offer losartan 25 mg, 50 mg, or 100 mg for $4 per 30-day supply or $10 per 90-day supply. No membership is required at Walmart. Costco pharmacy services are available to non-members in California under state pharmacy access law.

Free discount cards. GoodRx, RxSaver, and similar platforms aggregate pharmacy pricing and provide digital coupons. In the Los Angeles metro area, GoodRx pricing for losartan 50 mg (30 tablets) ranges from $4.00 at Costco to $11.47 at CVS. San Francisco pricing runs slightly higher, typically $5 to $13.

Manufacturer programs. Because losartan is generic, Merck does not offer a branded savings card for Cozaar in any meaningful capacity. Generic manufacturers do not run patient-facing discount programs. The savings pathway for generic drugs flows through pharmacy-level competition and discount aggregators rather than manufacturer coupons.

340B pharmacies. California has over 1,200 facilities participating in the federal 340B Drug Pricing Program, including federally qualified health centers (FQHCs), county hospitals, and certain community pharmacies. Patients who receive care at a 340B-covered entity can access losartan at deeply discounted prices, sometimes $0. Los Angeles County alone has more than 200 340B-enrolled sites. This is particularly relevant for uninsured patients who might otherwise face even modest cash-pay barriers.

Patient assistance foundations. NeedyMeds and RxAssist maintain directories of assistance programs, though for a drug priced at $4 to $10 per month, formal assistance applications are rarely necessary.

Compounded Losartan in California

Compounded losartan is legal in California when prepared by a 503A-licensed compounding pharmacy operating under California Board of Pharmacy oversight. The primary reason a patient would need compounded losartan is an inability to swallow tablets. Compounding pharmacies can prepare losartan as an oral suspension or liquid formulation.

The FDA's Cozaar label includes instructions for preparing an extemporaneous suspension from losartan tablets (mixing with Ora-Plus and Ora-Sweet), which means many retail pharmacies can compound this in-house without a specialized 503A license. Still, dedicated compounding pharmacies offer pre-made suspensions with longer beyond-use dating and custom concentrations.

Cost for compounded losartan oral suspension in California varies. Some 503A pharmacies charge $20 to $40 for a 30-day supply, while others include it at minimal markup if the patient also fills other prescriptions there. For pediatric patients requiring weight-based dosing (losartan is approved for hypertension in children aged 6 and older), compounded suspensions are sometimes the only practical option.

A key legal distinction: California permits 503A compounding based on an individual patient prescription. 503B outsourcing facilities can produce larger batches without patient-specific prescriptions, but losartan's wide generic availability makes 503B compounding uncommon for this drug. The California Board of Pharmacy maintains a database of licensed compounding pharmacies searchable by county.

Telehealth Prescribing in California

California fully permits telehealth prescribing of losartan. A licensed California prescriber (physician, nurse practitioner, or physician assistant) can evaluate a patient via video or audio-only visit, diagnose hypertension, and electronically prescribe losartan to any California pharmacy.

The Ryan Haight Act requires that controlled substances prescribed via telehealth meet specific DEA criteria, but losartan is not a controlled substance. No in-person visit is required before a California clinician prescribes losartan via telehealth. This has been the standard since California's telehealth parity legislation (SB 1665) codified audio-visual visit equivalence, and subsequent emergency provisions during 2020 to 2023 further expanded audio-only access.

Several telehealth platforms operating in California can prescribe losartan for $20 to $75 per consultation visit, with the medication cost separate. Combining a telehealth visit ($30 average for a basic hypertension consult) with a $4 generic fill means a California resident can go from zero care to medicated for under $35 total, without insurance. That figure is lower than most specialist copays.

For patients already managing hypertension, California law allows telehealth refill visits, meaning ongoing losartan prescriptions can be maintained without in-person appointments if the clinician and patient agree the condition is stable. The American Heart Association's 2023 scientific statement on telehealth for cardiovascular care supports remote management of hypertension as safe and effective when blood pressure monitoring data is available.

Clinical Background: Why Losartan Is Widely Prescribed

Losartan was the first angiotensin II receptor blocker (ARB) approved by the FDA, in 1995. It blocks the AT1 receptor, reducing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. The result is lower blood pressure without the dry cough that affects 5 to 20% of patients taking ACE inhibitors like lisinopril [2].

The LIFE trial (Lancet, 2002) compared losartan to atenolol in 9,193 patients with hypertension and left ventricular hypertrophy. Losartan reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol (P=0.021), with a particularly notable 25% reduction in stroke [3]. That stroke-reduction finding earned losartan an FDA-approved indication for reducing the risk of stroke in patients with hypertension and LVH.

In diabetic nephropathy, the RENAAL trial (NEJM, 2001) demonstrated that losartan 50 to 100 mg daily reduced the risk of doubling of serum creatinine by 25% and end-stage renal disease by 28% compared to placebo in patients with type 2 diabetes [4]. This trial established losartan as a renoprotective agent independent of its blood-pressure-lowering effect.

Dr. Barry Brenner, RENAAL's lead investigator, stated: "The renal protective effect of losartan is above and beyond what would be expected from blood pressure reduction alone." That principle, now embedded in guidelines from the American Diabetes Association and the Kidney Disease: Improving Global Outcomes (KDIGO) consortium, explains why losartan and other ARBs remain preferred agents in patients with diabetic kidney disease.

The ACC/AHA guideline panel noted in 2017: "ARBs are recommended as first-line agents for the treatment of hypertension to reduce cardiovascular events" (Class I, Level of Evidence A) [5]. Losartan, valsartan, irbesartan, and candesartan all hold this recommendation.

How Losartan Compares to Other ARBs on Cost in California

Losartan is the cheapest ARB available at California pharmacies, but not by a dramatic margin. A quick comparison of average California cash prices for a 30-day supply in 2026:

| ARB | Typical Dose | Average CA Cash Price | |---|---|---| | Losartan | 50 mg daily | $8, $12 | | Valsartan | 80 mg daily | $10, $18 | | Irbesartan | 150 mg daily | $12, $20 | | Olmesartan | 20 mg daily | $12, $22 | | Candesartan | 16 mg daily | $15, $28 | | Telmisartan | 40 mg daily | $10, $16 |

Losartan's cost advantage is modest. Clinical choice between ARBs typically depends on factors other than price: half-life (telmisartan has the longest at ~24 hours), uricosuric effect (losartan uniquely lowers uric acid, which may benefit patients with gout), and trial-specific evidence for particular conditions. The VALIANT trial supports valsartan post-myocardial infarction, while LIFE supports losartan for LVH with hypertension.

For patients whose only consideration is price, losartan and telmisartan are the least expensive options statewide.

Tips to Pay the Least for Losartan in California

Start with the $4 generic lists at Walmart, Costco, or Ralphs. If those pharmacies are inconvenient, check GoodRx or RxSaver for the lowest price at a pharmacy near your address. Ask your prescriber for a 90-day supply, which typically costs $10 to $12 at chains offering extended-fill discounts.

If you have Medi-Cal, use it. The copay will be $0 to $1. If you have commercial insurance and the copay exceeds $10, ask the pharmacist to run a GoodRx coupon instead of your insurance card. For Medicare Part D enrollees, compare your plan's cost against the GoodRx cash price each year at open enrollment; some Part D plans charge $0 for losartan, while others charge $8 to $12.

Patients filling losartan at a 340B-eligible clinic or FQHC in California may pay $0, regardless of insurance status. Contact your local community health center to ask if they participate.